title: Is HCFA's reimbursement policy controlling quality of care for end-stage renal disease patients?
authors.affiliation: Lynchburg Nephrology Dialysis, Inc, Virginia 24501, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Lockridge
authors.forename: J K
authors.initials: JK
authors.lastname: McKinney
mesh_terms: D014487:Centers for Medicare and Medicaid Services, U.S.; D003365:Costs and Cost Analysis; D006437:Hemodialysis, Home / Q000191:economics / Q000379:methods; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000628:therapy*; D011050:Policy Making; D011787:Quality of Health Care; D012051:Reimbursement Mechanisms; D017582:Renal Replacement Therapy / Q000191:economics*; D013997:Time Factors; D014481:United States